ALDX Latest Press Releases

-- February 18, 2026 --

Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference Business Wire 7:01 AM

-- December 15, 2025 --

Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease Business Wire 7:30 PM

-- November 13, 2025 --

Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast Business Wire 7:00 AM

-- November 11, 2025 --

Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London Business Wire 7:01 AM

-- November 6, 2025 --

Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET Business Wire 7:00 AM

-- October 28, 2025 --

Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules Business Wire 7:01 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software